Upcoming dates to note.

Our workshops and presentation days focus on four major topics: drug discovery and development, medical device development, diagnostics development and business funding.

At SPARK we believe that collaboration is key to success. Each SPARK cohort come together once a month to discuss their progress on the programme; to share their insights and learned experiences with one another.

We would also like to use SPARK as an opportunity to bring industry experts to the region to share their knowledge and opinion with those interested. We hope that this gives current and future translational scientists better understanding, and thereby the confidence, to bring their innovation to clinic.

SPARK Studio sessions are recorded with permission and these are linked below.

SPARK Studio recordings

  1. Importance of a Quality Management System (QMS)

Led by Henry Sibun, a consultant in the medical devices industry and an IRCA registered lead auditor for medical device quality management systems. 

3. Product Classification in the EU - The borderline area between medical devices and medicinal products

Theresa Jeary, Global Head of Medicinal and Biologics Team of BSI, a Notified Body, gives this talk.

5. Risk management in medical device development

Dr Peter Bowness from MCRA talks through the requirements from EU MDR 2017/745 and ISO 14971:2019 for medical devices.

2. From gene to clinical candidate: a (very brief) overview of target-based drug discovery

Presented by Dr Ben Davis, Director of Business Development and Research Fellow at Vernalis Research, a biotech company.

4.Drugs, Devices and Diagnostics: broad brush, real-world experience

A ‘fireside chat’ with Will Burton, who previously managed the Manufacturer Registration Scheme Business Unit of the UK Medical Devices Agency (now MHRA). Now the founding Director of Russell Square Quality Representatives (RSQR) Ltd.